Goal and Learning Outcomes

Upon completion of this activity, participants should be better able to:

  • Differentiate idiopathic pulmonary fibrosis (IPF) from other common ILDs, such as connective tissue disease ILD (CTD-ILD), accurately and efficiently using recommended clinical evaluation, radiologic testing, and pathologic testing as needed
  • Apply evidence informing the use of antifibrotic therapy, nonpharmacologic strategies, and management of risk factors and comorbidities in patients with IPF to formulate treatment plans
  • Individualize treatment of IPF based on patient characteristics and preferences, using shared decision-making

Agenda

  • Introduction: The “Alphabet Soup” of ILDs
  • Differential Diagnosis of ILDs
  • Managing IPF: Comprehensive, Patient-Centered Care
  • Q&A

Accreditation Information

This course is being provided by a Relias LLC strategic partner.  Consumption of this course will take place on the partners site and courses provided in this manner are not accredited by Relias LLC.